Patents - Global Data - Dimensions
RECOMBINANT MVA VIRUSES FOR INTRAPERITONEAL ADMINISTRATION FOR TREATING CANCER
Applicants:
- Bavarian Nordic (Denmark) [NORA names: Bavarian Nordic; Private Research; Denmark; Europe, EU; Nordic; OECD]
Abstract
The invention relates to methods for treating cancer and/or increasing the survival of a cancer patient. The composition comprises a recombinant MVA encoding a Tumor Associated Antigen ("TAA") as well as 4-1BBL and/or CD40L and is administered to a subject intraperitoneally.
Patent Family Records (1)
RECOMBINANT MVA VIRUSES FOR INTRAPERITONEAL ADMINISTRATION FOR TREATING CANCER
BAVARIAN NORDIC AS, Bavarian Nordic (Denmark) HINTERBERGER MARIA, MEDINA ECHEVERZ JOSÉ, HABJAN MATTHIAS, (...more)
2023, WO-2023118508-A1
